Latest Breaking News On - Allergopharma gmbh co - Page 2 : comparemela.com

Athens Times The EMA approved 2 additional production Places for the Pfizer vaccine The EMA Committee on Human Medicines (CHMP) announced that it has approved two additional production sites for Comirnaty, the COVID-19 vaccine developed by BioNTech and Pfizer. Published The EMA Committee on Human Medicines (CHMP) announced that it has approved two additional production sites for Comirnaty, the COVID-19 vaccine developed by BioNTech and Pfizer. Allergopharma GmbH & Co. KG. and the other in Stein, Switzerland and is managed by Novartis Pharma. The two production lines will carry out final product manufacturing steps at different stages of the process and are expected to support Comirnaty’s ongoing supply to the European Union.

Schleswig holsteinNovartis pharmaEuropean unionCommittee on human medicinesAllergopharma gmbh coHuman medicinesAllergopharma gmbhஸ்சிலேசுவிக் ஹோல்ஸ்டீன்நோவர்த்திச் பார்மாஐரோப்பிய தொழிற்சங்கம்குழு ஆன் மனிதன் மருந்துகள்மனிதன் மருந்துகள்